David Barney, PAC

NPI: 1437254430
Total Payments
$16,069
2024 Payments
$4,351
Companies
52
Transactions
1,069
Medicare Patients
386
Medicare Billing
$38,939

Payment Breakdown by Category

Food & Beverage$16,005 (99.6%)
Education$63.90 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $16,005 1,065 99.6%
Education $63.90 4 0.4%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $3,516 252 $0 (2024)
ABBVIE INC. $1,971 179 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,521 64 $0 (2024)
Lilly USA, LLC $1,302 83 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $854.16 42 $0 (2024)
Otsuka America Pharmaceutical, Inc. $770.68 70 $0 (2024)
GlaxoSmithKline, LLC. $597.03 58 $0 (2024)
PFIZER INC. $588.37 27 $0 (2024)
Supernus Pharmaceuticals, Inc. $513.89 40 $0 (2024)
ITI, Inc. $373.70 22 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,351 250 ABBVIE INC. ($596.79)
2023 $3,839 239 Novo Nordisk Inc ($662.73)
2022 $4,243 301 Novo Nordisk Inc ($990.17)
2021 $3,637 279 Novo Nordisk Inc ($1,279)

All Payment Transactions

1,069 individual payment records from CMS Open Payments — Page 1 of 43

Date Company Product Nature Form Amount Type
12/19/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $25.27 General
Category: RESPIRATORY
12/18/2024 Lilly USA, LLC KISUNLA (Drug), ZEPBOUND Food and Beverage In-kind items and services $23.01 General
Category: Neuroscience
12/17/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $15.82 General
Category: Respiratory
12/17/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $11.79 General
Category: PSYCHIATRY
12/13/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $17.05 General
Category: Obesity
12/12/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $22.02 General
Category: PSYCHIATRY
12/12/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $11.25 General
Category: NEUROSCIENCE
12/11/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $21.97 General
Category: PAIN
12/10/2024 Teva Pharmaceuticals USA, Inc. AJOVY (Biological) Food and Beverage In-kind items and services $18.43 General
Category: Central Nervous System
12/10/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $18.00 General
Category: RESPIRATORY
12/10/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $1.23 General
Category: RESPIRATORY
12/05/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.56 General
Category: NEUROSCIENCE
12/04/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $17.72 General
Category: Respiratory
12/04/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $7.09 General
Category: NEUROSCIENCE
12/03/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $20.46 General
Category: Cardio-renal
12/03/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $18.01 General
Category: VILOXAZINE HYDROCHLORIDE
12/03/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $6.90 General
Category: VILOXAZINE HYDROCHLORIDE
12/02/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $21.09 General
Category: Obesity
11/27/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $15.62 General
Category: PSYCHIATRY
11/25/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $21.27 General
Category: PSYCHIATRY
11/20/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $21.59 General
Category: Diabetes
11/20/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $20.13 General
Category: Diabetes
11/19/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $8.68 General
Category: NEUROSCIENCE
11/18/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $27.37 General
Category: Obesity
11/14/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $18.94 General
Category: PAIN

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 95 174 $25,234 $8,858
2022 3 90 171 $22,531 $9,520
2021 4 95 197 $23,005 $10,416
2020 3 106 240 $29,136 $10,146
Total Patients
386
Total Services
782
Medicare Billing
$38,939
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 44 112 $15,053 $5,105 33.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 26 37 $7,046 $2,229 31.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 14 14 $2,738 $1,458 53.2%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 11 11 $396.00 $64.89 16.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 52 128 $15,232 $5,581 36.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 21 21 $3,619 $2,285 63.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 17 22 $3,680 $1,654 44.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 52 135 $15,120 $6,611 43.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 17 31 $4,960 $2,018 40.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 15 15 $2,445 $1,632 66.8%
83036 Hemoglobin a1c level Office 2021 11 16 $480.00 $155.36 32.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 71 194 $21,728 $7,172 33.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 16 16 $2,608 $1,514 58.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 19 30 $4,800 $1,460 30.4%

About David Barney, PAC

David Barney, PAC is a Medical healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437254430.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Barney, PAC has received a total of $16,069 in payments from pharmaceutical and medical device companies, with $4,351 received in 2024. These payments were reported across 1,069 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($16,005).

As a Medicare-enrolled provider, Barney has provided services to 386 Medicare beneficiaries, totaling 782 services with total Medicare billing of $38,939. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Medical
  • Location Grand Rapids, MI
  • Active Since 09/14/2006
  • Last Updated 11/14/2018
  • Taxonomy Code 363AM0700X
  • Entity Type Individual
  • NPI Number 1437254430

Products in Payments

  • VRAYLAR (Drug) $1,127
  • Wegovy (Drug) $1,071
  • REXULTI (Drug) $881.32
  • Saxenda (Drug) $740.49
  • FARXIGA (Drug) $686.88
  • Ozempic (Drug) $679.24
  • JARDIANCE (Drug) $673.13
  • CAPLYTA (Drug) $607.95
  • MOUNJARO (Drug) $585.78
  • Rybelsus (Drug) $576.86
  • TRELEGY ELLIPTA (Drug) $525.43
  • NURTEC ODT (Drug) $416.14
  • RYBELSUS (Drug) $350.97
  • Kerendia (Drug) $347.85
  • Qelbree (Drug) $297.09
  • BREZTRI (Drug) $290.24
  • STIOLTO RESPIMAT (Drug) $259.44
  • TRULICITY (Drug) $251.27
  • QULIPTA (Drug) $247.50
  • AIRSUPRA (Drug) $227.44

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Medical Doctors in Grand Rapids